[{"id":"2b6e1463-c371-4b17-a2c1-81d56ff0988e","acronym":"","url":"https://clinicaltrials.gov/study/NCT03215511","created_at":"2021-01-18T15:52:01.409Z","updated_at":"2025-02-25T17:09:49.126Z","phase":"Phase 1","brief_title":"A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer","source_id_and_acronym":"NCT03215511","lead_sponsor":"Bayer","biomarkers":" NTRK3 • ETV6 • NTRK","pipe":" | ","alterations":" NTRK fusion","tags":["NTRK3 • ETV6 • NTRK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NTRK fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e selitrectinib (BAY 2731954)"],"overall_status":"Completed","enrollment":" Enrollment 81","initiation":"Initiation: 07/03/2017","start_date":" 07/03/2017","primary_txt":" Primary completion: 04/11/2022","primary_completion_date":" 04/11/2022","study_txt":" Completion: 01/30/2023","study_completion_date":" 01/30/2023","last_update_posted":"2024-10-30"},{"id":"25c64f33-801c-46c5-8cbf-381cc597fe7f","acronym":"","url":"https://clinicaltrials.gov/study/NCT03206931","created_at":"2021-01-18T15:48:28.443Z","updated_at":"2025-02-25T17:09:47.148Z","phase":"","brief_title":"Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion","source_id_and_acronym":"NCT03206931","lead_sponsor":"Bayer","biomarkers":" NTRK1 • NTRK3 • NTRK2","pipe":" | ","alterations":" NTRK1 fusion • NTRK3 fusion • NTRK2 fusion","tags":["NTRK1 • NTRK3 • NTRK2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NTRK1 fusion • NTRK3 fusion • NTRK2 fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e selitrectinib (BAY 2731954)"],"overall_status":"No Longer Available","enrollment":"","initiation":"","start_date":"","primary_txt":"","primary_completion_date":"","study_txt":"","study_completion_date":"","last_update_posted":"2021-09-16"}]